MKI67 and glioblastoma: Quantification of immunohistochemistrywas used to detect Ki67expression in glioblastoma cells at brain slices, and the resultsare presented in Figure 7J. Proliferation assay indicated that cells expressing Ki67 decreased20% in the CPT-ALA group.